InvestorsHub Logo
Followers 17
Posts 1579
Boards Moderated 0
Alias Born 05/15/2018

Re: None

Wednesday, 07/17/2019 12:24:02 PM

Wednesday, July 17, 2019 12:24:02 PM

Post# of 71146
Now let’s re-look and the May 24th News Letter in this new light.

1. First paragraph: “The isolate/distillate markets have made a predictable swing this year away from isolates and more towards full or broad-spectrum distillate to take advantage of the benefits of the whole plant. As with all products and extractions associated with NNRX, our products have less than .3% THC, making them federally legal (with zero psychoactive effect) under the existing and somewhat cloudy laws regarding CBD.” Note: “our products have less than .3% THC” Is this a slip on the tong are they already developing CBD products for future sales.

2. Second paragraph: “On deck for a complete redesign is our top seller” & “This new delivery system provides for an almost instantaneous delivery into the bloodstream to provide the most immediate results” & “The product will be ready within 12 weeks with new branding and packaging to reflect our newly invigorated approach to health”. These quotes show redesign of existing product line (vitamins & minerals) using nano technology recent partner help (Tempo)? 12 weeks (end of Aug./summer), new branding?
3. Sixth paragraph: “we have two other products ready to be branded and brought to market, including our first product with CBD in a nano-sized format and featuring mangosteen, another powerful anti-inflammatory component.” New products in production? Same 12 weeks time line, note CBD mention.
4. Seven paragraph: “NUTRANOMICA UK LIMITED. In the near future, press releases regarding the specifics of this subsidiary and its operators will be disclosed. We will also be in a position to announce all farming and acreage, both domestically and internationally, that has been finalized at that time. Key metrics for disclosure includes full execution of all agreements, funding in place, and approval for release publicly of quotes and information by our partners” There not going to make the same mistake they made in Feb. (Waldren).
5. Next to last paragraph: “Our goal is to provide transparency while remaining true to the covenants made to the markets and required by law. This is not always an easy aspect to straddle. During the first half of this year, we have poured all our efforts into our BioMedical and Wholesale Materials Divisions, turning now to a greater focus on Contract Services and Sales. We will be able to transition more time and effort into communications, but if they are sporadic, just know there is a good reason for it.” They are going to do things the right way this time. Things don’t happen over night.

Re-read the whole May 24th. News letter there’s more than what I highlighted.
These are my opinions when you re-read news letter form your own opinions.